ReviewRSC advances2022
Rational drug design of CB2 receptor ligands: from 2012 to 2021.
Yan-Ran Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ReviewRSC advances2022
Yan-Ran Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.